
Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma
Author(s) -
Rebecca Zhu,
Fangfang Liu,
Gabriella Grisotti,
Javier Pérez-Irizarry,
Ronald R. Salem,
Charles Cha,
Kimberly L. Johung,
Daniel J. Boffa,
Yawei Zhang,
Sajid Khan
Publication year - 2018
Publication title -
journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.084
H-Index - 39
eISSN - 2219-679X
pISSN - 2078-6891
DOI - 10.21037/jgo.2018.03.05
Subject(s) - medicine , cancer , gastrectomy , adjuvant therapy , chemotherapy , adenocarcinoma , radiation therapy , adjuvant , oncology , surgery
Adjuvant therapy for gastric adenocarcinoma has shown a survival advantage, though it may be underutilized. The purpose of this study is to examine how infrequently adjuvant therapy is administered with curative intent gastrectomy for node positive gastric cancer and the long-term effects to patients.